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Chronic aristolochic acid toxicity in rabbits: A model of Chi- Its precise cause remains a matter of debate. Aristo-
nese herbs nephropathy? lochic acid (AA) has been incriminated as it was found
Background. Chinese herbs nephropathy (CHN) is a new in a Chinese herbs combination [4], probably as a resulttype of subacute interstitial nephritis that is attributed to aristo-
of the inadvertent substitution of Aristolochia fangchilochic acid (AA), which inadvertently has been included in
slimming pills. The contribution of other simultaneously pre- for Stephania tetrandra. This hypothesis was supported
scribed drugs remains disputed. In the present study, the effects by the discovery of AA-DNA adducts in the kidneys of
of a chronic intake of AA given as a single drug was evaluated CHN patients [3, 5, 6]. However, the fact that only athrough renal histology and function in rabbits.
minority of the treated patients developed kidney dis-Methods. Female New Zealand White rabbits were injected
ease and that other compounds were simultaneouslyintraperitoneally with either 0.1 mg AA/kg or with saline 5 days
a week for 17 to 21 months. Body weight, renal function, and given precluded definitive conclusions [3].
urinary excretion of glucose and low molecular weight proteins Although high doses of AA cause acute tubular necro-
were monitored prior to sacrifice at the end of the study period.
sis [7–10], there is no experimental model demonstratingResults. All animals given AA developed renal hypocellular
its chronic nephrotoxicity. Indeed, rats given a chronicinterstitial fibrosis, which was classified into three patterns. Fibro-
sis was confined to medullary rays (MRs) in pattern I (N 5 3), oral dose of AA, either alone or mixed with several other
extended to the outer cortical labyrinth (OCL) in pattern II drugs included in the slimming pills, failed to develop
(N 5 2), and eventually to the inner cortical labyrinth (ICL)
chronic renal lesions despite the appearance of digestivein pattern III (N 5 6). Fibrosis in MR and OCL was associated
and urinary tract malignancies [11].with mainly proximal tubular epithelial cell flattening. All
treated animals displayed urothelial atypia. Three of them also As emphasized in a recent editorial, this topic is of in-
developed tumors of the urinary tract. No significant pathologic terest not only to nephrologists but also to those concerned
changes were found in control rabbits. AA-treated animals with drug safety and phytotherapy in particular [12].differed from controls by an impaired growth, increased serum
The present study was thus undertaken to evaluatecreatinine, glucosuria, tubular proteinuria, and anemia.
Conclusion. The observed pattern of renal histopathological whether another animal model, the rabbit, presented any
lesions and disorders of the renal function, as well as urothelial renal anomalies following chronic administration of AA
atypia and malignancy, are very reminiscent of CHN. Our given as a single drug without an admixture of the otherobservations therefore support a causal role of AA alone in
components of the slimming cure. The relevance of thethe genesis of this new nephropathy.
observed anomalies in comparison to those characteriz-
ing CHN is assessed.
Chinese herbs nephropathy (CHN), a subacute renal
interstitial fibrosis [1] associated with the frequent develop- METHODS
ment of urothelial cancer [2, 3], has been discovered in
Aristolochic acidpatients who had followed a slimming cure containing Chi-
nese herbs Magnolia officinalis and Stephania tetrandra. The natural mixture of AA was purchased from Sigma
Aldrich Co. (St. Louis, MO, USA). According to the
manufacturer, this mixture is 97% pure. The same mix-Key words: toxic interstitial nephritis, urothelial atypia, fibrosis, cancer,
slimming pills. ture submitted to high-performance liquid chromatogra-
phy analysis yielded 44% AAI and 56% AAII [11].Received for publication October 23, 2000
NaOH 25 mmol/L was used to dissolve 5 g AA crystals/Land in revised form January 11, 2001
Accepted for publication January 16, 2001 saline. Prior to injection, this solution was further diluted
50 times in saline to obtain 0.1 g AA/L.Ó 2001 by the International Society of Nephrology
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Animals, environment, and AA dosage tized with an intramuscular injection of 25 mg/kg keta-
mine (Anesketin, 100 mg/mL) and 5 mg/kg xylazineTwelve 15-week-old female New Zealand white rabbits
(Rompun, 20 mg/mL), and their arterial blood pressureweighing 3510 6 225 g were used after a one-month accli-
was monitored with a pressure monitor (Honeywell, RMmatization period. AA was given by intraperitoneal injec-
300) through a carotid artery catheter.tion at the dose of 0.1 mg/kg (a nonlethal amount deter-
Samples of the lungs, heart, liver, pancreas, spleen,mined in a pilot study), 5 days a week for 17 (N 5 6) to
stomach, small and large intestines, kidneys, adrenals,21 months (N 5 6). Ten female control rabbits received
urinary bladder, female genital tract, salivary glands,intraperitoneal saline only for 17 (N 5 5) to 21 months
tongue, trachea, esophagus, brain, skin, and skeletal mus-(N 5 5). The animals were kept in individual steel cages
cle, as well as any tissue with abnormal appearance, werein fully air-conditioned rooms with an artificial light–
taken and fixed in formalin and/or Duboscq-Brasil fordark cycle. The temperature was maintained at 22 6
histologic examination. Paraffin sections were stained38C, with a relative humidity of 45 6 20%. Standardized
with hematoxylin and eosin.food pellets (Lapina-Profit N8 661, Dossche, Deinze, Bel-
The extent of interstitial fibrosis, edema, cellular infil-gium) and tap water were available ad libitum.
tration, tubular atrophy, thickening of basement mem-
branes, and flattening of epithelial cells were semiquanti-Blood and urinary chemistry
tatively estimated in the various structures of whole kidney
Blood samples were taken on day 0 and months 8, 10, sections: medullary rays (MRs), outer (OCL) and inner
12, 14, 15, 16, 17, 18, 19, 20, and 21 after the start of the (ICL) cortical labyrinth, outer (OM) and inner (IM)
injections for measurement of serum creatinine. Twenty- medulla. A low magnification (350) was used for intersti-
four–hour urine output was measured on days 3, 10, and tial fibrosis, and a 3200 magnification was used for the
17 and on months 1, 2, 3, 5, 10, 12, 14, 16, 17, 18, 19, and other abnormalities. Results were scored according to
21 after the start of the injections. Urine samples were the fraction of the total area involved by the pathological
stored at 2208C until used for measurement of glucosu- process: score 0 5 absent; score 1 5 minimal, 1 to 9%;
ria, creatininuria, and proteinuria. Glucose, hemoglobin, score 2 5 mild, 10 to 29%; score 3 5 moderate, 30 to
and serum protein levels were measured in blood sam- 59%; and score 4 5 severe, 60 to 100%. Kidney cortical
ples obtained at the end of the experiment in both width was measured by computer-assisted morphometry
groups. One concentrated urine sample was obtained 2 (MOP-Videoplan; Kontron, Mu¨nchen, Germany). Corti-
weeks prior to the end of the experiment in the animals cal width was defined as the mean of 10 consecutive
injected for 17 months (controls and treated). Its protein distances covered at right angle with the renal capsule
content was analyzed by sodium dodecyl sulfate-poly- to the mid part of the outer walls of arcuate arteries and
acrylamide gel (SDS-PAGE) electrophoresis (Phar- of a line drawn between the latter.
macia PhastSystem, Uppsala, Sweden) on 20% poly- Atypia of collecting ducts and urothelium were esti-
acrylamide gel and stained with the Phast Gel Silver Kit. mated as mild, moderate, or severe according to both
The following routine laboratory methods were run on severity and number of atypical cells. Right and left
an automated analyzer Hitachi 917 (Roche Diagnostic, collecting ducts, pelvicalyces, upper, mid, and lower ure-
Mannheim, Germany): The Jaffe reaction adapted by ters were assessed separately but are reported together.
Bartels, Bohmer, and Heierli [13] for serum and urinary
Statistical analysiscreatinine, the hexokinase method [14] for serum glu-
cose, and the Biuret reaction [15] for serum proteins. Data were analyzed with the BMDP New System Pro-
The glucose deshydrogenase [16] and the pyrogallol red fessional Edition statistical software (Registered trade-
coloration in the presence of molybdate [17] methods mark of Statistical Solutions Inc., University of California
were run on an automated analyzer Axon (Bayer Diag- Press, Berkeley, CA, USA, 1995). The study design in-
nostics Division, Technicon Ames Miles, Diegem, Bel- cluded repeated measures of eight variables (weight and
gium) for the determination of urinary glucose and pro- seven renal biological indices) on rabbits grouped into
teins, respectively. The Drabkin method adapted by two parallel arms (AA-treated and control). Body weight
Matsubara was run on an automated analyzer Bayer H3 and variables derived from urine output and from blood
(Bayer Diagnostics Division, Diegem, Belgium) for blood sample were repeatedly measured (31, 13, and 8 times
hemoglobin levels [18]. over 17 months and 39, 16, and 12 times over 21 months).
For each rabbit, the response curve of each variable was
Sacrifice and postmortem examinations summarized by the T area and by the slope. T area was
Aristolochic acid-treated and control rabbits were sac- defined as the ratio between the area under the curve
rificed at the end of the experiment by an intravenous via the trapezoidal rule and the length of the period (17
injection of 5 mL sodium pentobarbitone (Nembutal 60 or 21 months). Such a statistic has the same unit as the
mg/mL). Immediately before sacrifice, the animals fol- response variable; it is interpreted as the overall mean
value of the variable during the intoxication interval.lowed for 21 months (controls and treated) were anesthe-
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Table 1. Median score of renal interstitial fibrosis and of other tubulointerstitial lesions in female New Zealand white rabbits injected with
intraperitoneal 0.1 mg AA/kg/day 5/7 days during 17 (N 5 5) and 21 (N 5 6) months and in control animals (N 5 10)
OM
OCL ICL MR OS/MR OS/ICL IS Whole OM IM
Interstitial fibrosis
AA-treated 4 (2–4) 2 (0–3) 4 2 (2–3) 2 (1–3) 1 (0–2) 2 (1–3) 0 (0–2)
Control 0 0 0 0 0 0 0 0
Proximal tubular cell flattening
AA-treated 4 (3–4) 3 (1–4) 3 (1–4) ND ND ND 4 (3–4) 0 (0–1)
Control 0 0 0 ND ND ND 0 0
Tubular atrophy
AA-treated 3 (2–4) 1 (0–3) 2 (0–4) ND ND ND 1 (0–2) 0
Control 0 0 0 ND ND ND 0 0
Thickened tubular basement membrane
AA-treated 3 (0–4) 1 (0–3) 1 (0–4) ND ND ND 2 (0–3) 0 (0–3)
Control 0 0 0 ND ND ND 0 0
Interstitial edema
AA-treated 4 (0–4) 3 (0–4) 3 (0–4) ND ND ND 3 (0–4) 0 (0–1)
Control 0 0 0 ND ND ND 0 (0–1) 0 (0–2)
Interstitial cellular infiltrationa
AA-treated 1 (0–2) 1 (0–2) 1 (0–2) ND ND ND 1 (0–2) 0
Control 0 0 0 ND ND ND 0 0
Data are median score with the range in brackets. Scores are: 0 (#0.9% or absent); 1 (1%–9% or minimal); 2 (10%–29% or mild); 3 (30%–59% or moderate);
4 (60%–100% or severe). Abbreviations are: AA, aristolochic acid; OCL, outer cortical labyrinth; ICL, inner cortical labyrinth; MR, medullary ray; OM, outer
medulla; OS/MR, outer stripe of outer medulla in front of MR; OS/ICL, outer stripe of outer medulla in front of ICL; IS, inner stripe of outer medulla; IM, inner
medulla; ND, not determined.
a Interstitial cellular infiltration assessed according to the Banff criteria [35], which evaluated the extent rather than the intensity of the infiltrate
became significant. All statistical tests were two tailed.
A P value ,0.05 was considered as significant. Data are
reported as mean 6 SEM.
RESULTS
Eight months after initiation of the intraperitoneal
injections, one AA-treated rabbit of the 17-month group
was found dead. Its serum creatinine level, determined
on postmortem intracardiac punction, was 4.36 mg/dL.
Histologic examination of kidneys disclosed postmortem
lytic changes and incipient fibrosis, mainly at MRs. This
animal is not included in the results. All other treated
and control animals (N 5 21) survived until sacrifice.Fig. 1. Extensive, hypocellular interstitial fibrosis and tubular atrophy
in outer cortical labyrinth (OCL) of a female New Zealand white rabbit
Morphological datainjected with intraperitoneal 0.1 mg aristolochic acid (AA)/kg/day for
17 months (hematoxylin and eosin stain, 3260). Results were similar in the 17-month (N 5 5) and 21-
month (N 5 6) AA-treated animals. Both groups were
thus considered together. In the AA-treated animals,The slope was defined as the coefficient b of a regression
fibrotic changes were observed in the kidneys and theline of the variable over time; this statistic is interpreted
stomach; tumors developed in the urinary tract and theas the overall increase in variable mean per unit of time
peritoneal cavity. No abnormalities were found in the sam-(months). A Mann–Whitney U test was then performed
ples taken from lungs, heart, liver, pancreas, spleen, smallon each of these two statistics in order to compare AA-
and large intestines, adrenals, urinary bladder, femaletreated with control rabbits. If the difference in T area
genital tract, salivary glands, tongue, trachea, esophagus,was not significant, no further comparisons were made
brain, skin, and skeletal muscle. In the control animals,between response curves. When the T area was signifi-
no significant abnormalities were found.cant, it indicated an overall effect, but just as for analysis
of variance (ANOVA), it failed to identify the time
Kidneys and urinary tractpoints at which the difference became significant. When
Macroscopic aspects. Kidney weights were higher inthis was found to be the case, raw data were used to
AA-treated than in control animals. The right and leftcompare the two groups at each time-point measurement
in order to identify at which time-point the difference kidney weight (mg/cm2 of body surface) averaged 4.6 6
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Fig. 2. Patterns of renal interstitial fibrosis in female New Zealand white rabbits after a 17- to 21-month regimen of an intraperitoneal injection
of 0.1 AA mg/kg/day. (A) Cortical labyrinth and medullary rays (MR) (arrows) of control rabbit. (B) Interstitial fibrosis mainly in MR (arrows;
pattern I) and mildly in outer cortical labyrinth (OCL) (full arrowheads). (C) Extensive interstitial fibrosis and tubular atrophy in MR, moderate
and mild fibrosis in OCL (full arrowheads) and in inner cortical labyrinth (ICL) (hollow arrowhead), respectively (pattern II). (D) Severe interstitial
fibrosis and tubular atrophy in MR and OCL, moderate fibrosis in ICL (hollow arrowheads; pattern III) (hematoxylin and eosin stain, 34).
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Table 2. Median score of renal interstitial fibrosis according to the severity of OCL fibrosis ranked into pattern I (N 5 3), II (N 5 2) and
III (N 5 6) AA-treated (N 5 11) and in control (N 5 10) rabbits
OM
OCL ICL MR OS/MR OS/ICL IS IM
Pattern I 2 0 (0–1) 4 2 1 0 (0–1) 0
Pattern II 3 1.5 (1–2) 4 2.5 (2–3)a 2 (1–3)a 1.5 (1–2)a 1 (0–2)a
Pattern III 4 3 (2–3) 4 2 2 (1–2) 1 0 (0–1)
Controls 0 0 0 0 0 0 0
Data are median score with the range in brackets. Scores are: 0 (#0.9% or absent); 1 (1%–9% or minimal); 2 (10%–29% or mild); 3 (30%–59% or moderate);
4 (60%–100% or severe). Abbreviations are: AA, aristolochic acid; OCL, outer cortical labyrinth; ICL, inner cortical labyrinth; MR, medullary ray; OM, outer
medulla; OS/MR, outer stripe of outer medulla in front of MR; OS/ICL, outer stripe of outer medulla in front of ICL; IS, inner stripe of outer medulla; IM, inner
medulla.
a Likely superimposed tubulointerstitial pyelonephritis in one animal of this group
1.2 and 4.7 6 1.2, respectively, in AA-treated versus 2.6 6 leukocytes. Irrespective of the pattern, severity of fibrosis
decreased from the outer cortex to the IM. Figure 30.7 and 2.6 6 0.5, respectively, in control rabbits (P ,
summarizes schematically the findings in each of the0.01). The external surface was smooth. The cortex width
three pathological patterns.was uniformly thinner in AA-treated (2.05 6 0.21 mm)
The severity of the other tubular and interstitial lesionsthan in control (2.68 6 0.24 mm) animals (P , 0.0001).
present in the three patterns is summarized in Table 3.Macroscopic examination of the pelves, ureters, and
Proximal tubular epithelial cell flattening increased inbladder was unremarkable.
severity from pattern I to pattern III. Tubular atrophyMicroscopic aspects. Renal interstitial fibrosis and other
increased in severity from patterns I to III mainly in OCLtubulointerstitial lesions are summarized in Table 1. In
and ICL. Thickening of tubular basement membranescontrol rabbits, interstitial fibrosis and other tubulointer-
increased in severity from patterns I to III in all compart-stitial lesions were absent (Fig. 2A). In all AA-treated
ments except in IM. Interstitial edema was moderaterabbits, in contrast, hypocellular interstitial fibrosis was
and similar in all compartments (except in IM, where itassociated with tubular atrophy (Fig. 1). Interstitial fi-
was absent) irrespective of pattern. Interstitial cellularbrosis was severe in OCL and MR; mild in ICL, outer
infiltrate was minimal in all compartments in patterns IIstripe of OM; minimal in IS; and absent in IM. Proximal
and III only.tubular epithelial cell flattening was severe in OCL and
Glomerular lesions were absent in the control rabbitsOM; moderate in ICL and MR; and absent in IM. Tubu-
and overall rather mild in the AA-treated animals. Inlar atrophy was moderate in OCL, mild in MR, minimal
seven animals (1 pattern II, 6 pattern III), incipient scle-in ICL and OM, and absent in IM. Thickening of tubular
rotic changes were observed in OCL areas with the mostbasement membranes was moderate in OCL, mild in
severe tubulointerstitial lesions.OM, minimal in ICL and MR, and absent in IM. Intersti-
All arteries were normal, irrespective of size, in bothtial edema was severe in OCL; moderate in ICL, MR,
AA-treated and control animals.and OM; and absent in IM. Interstitial cellular infiltration Tumors developed in the kidney of two AA-treated
was minimal in all compartments, except in IM, where animals, whereas none was found in controls: An in situ
it was absent. Tubular nonhemoglobin pigmented casts renal cell carcinoma developed in two nephrons of the
were occasionally present only in convoluted parts of OM of one animal treated for 17 months, and a single
proximal tubules of half of the animals. tubulopapillary adenoma (5 3 13 mm) was found in one
To assess further the lesions in the treated rabbits, animal treated for 21 months. Mild to moderate atypias
three different patterns were isolated on the basis of the were seen in the epithelial lining of the collecting ducts
severity of interstitial fibrosis in the OCL: pattern I (score (5 out of 11 treated vs. 0 out of 10 control rabbits, Fisher’s
2, N 5 3), pattern II (score 3, N 5 2), pattern III (score exact test, P 5 0.035) and in the urothelium of the pelvis
4, N 5 6; Table 2). In the MR, interstitial fibrosis was (11 out of 11 treated vs. 3 out of 10 control animals,
uniformly severe (score 4) irrespective of the pattern Fisher’s exact test, P 5 0.001). A flat, high-grade transi-
(Fig. 2 B–D). In the ICL, interstitial fibrosis was absent tional cell carcinoma (TCC) invading the lamina propria
in pattern I (score 0) but increasingly severe in patterns was found in the right midureter of one rabbit treated
II and III (scores of 1.5 and 3; Fig. 2 C, D, respectively). for 21 months. This animal also harbored an extensive
In the OM, fibrosis was overall mild (score of 1 to 2.5) papillary malignant mesothelioma of the peritoneal cav-
in the outer stripe and minimal (score of 0 to 1.5) in the ity, focally invading the submesothelial tissue.
inner stripe, irrespective of the pattern. It was virtually
Stomachabsent in the IM. Of note, one of the two pattern II
animals had a severe OM and IM fibrosis probably due Microscopic examination revealed significant multifo-
to pyelonephritic lesions as fibrotic areas were infiltrated cal paucicellular stromal fibrosis associated with glandu-
lar atrophy of the gastric mucosa in AA-treated rabbits.by chronic inflammatory cells and polymorphonuclear
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The degree of fibrosis was rated moderate (N 5 7) or Correlation between biologic data and extension of
interstitial fibrosissevere (N 5 4) in AA-treated rabbits. These observations
contrasted with the findings in control rabbits, where The biologic results could not be meaningfully com-
fibrosis was mild in nine cases and moderate in one. pared among the three groups of pathologic patterns of
AA-treated rabbits as a result of their small size. How-
Biologic data ever, it should be emphasized that glucosuria was highest
The evolution of body weight, renal function, and uri- in pattern III and that the values of the mean monthly
nary parameters in treated and control animals, as well rise observed both for serum creatinine and proteinuria
as the statistical significance of the observed differences, increased from pattern I to pattern III (data not shown).
is presented in Table 4.
The body weight of AA-treated animals was signifi-
DISCUSSIONcantly lower than that of control rabbits. The difference
The present study demonstrates, to our knowledge forbecame statistically significant from the second month
the first time, that chronic administration of the naturalonward. Monthly body weight gain averaged 6 6 7 g in
mixture of AAs may induce renal interstitial fibrosis.AA-treated versus 97 6 10 g in control rabbits (P ,
Repeated daily intraperitoneal injection of female New0.001). Food intake was measured one month before
Zealand White rabbits with 0.1 mg/kg/day of AA for upsacrifice in the 17-month AA-treated rabbits by weighing
to 21 months results in a paucicellular renal interstitialthe food containers filled with pellets at 0 and 24 hours
fibrosis with a striking corticomedullary gradient. Theselater. It was markedly lower (96 6 29 g) in AA-treated
pathological changes are associated with mild renal dys-than in control rabbits (195 6 63 g, P 5 0.0079).
function and a severely impaired growth.Serum creatinine was significantly higher in AA-
Only 21 rabbits [AA-treated (N 5 11) and controltreated than in control rabbits. The difference reached
animals (N 5 10)] were included in this study. Neverthe-statistical significance at 16 months. Urine output was
less, the development of renal fibrosis in all AA-treatedsignificantly higher in treated than in control animals.
versus none in control rabbits as well as the fact thatThe difference became apparent at three months and
several biologic parameters differ significantly betweenreached statistical significance from 12 months onward.
treated and control animals indicates that this numberCreatinine clearance (in mL/min and in mL/min/kg) and
was sufficient.
creatininuria were not statistically different in treated
The lower weight gain observed in AA-treated rabbits
and control rabbits. Glucosuria was significantly higher likely reflects some degree of anorexia, as two times
in treated than in control animals. It appeared at four lower food intake was documented in five AA-treated
months. The difference reached statistical significance rabbits at 16 months. The AA-associated gastric lesions
after 12 months. Proteinuria was significantly higher in may play an additional role. The normal serum protein
treated than in control animals and appeared at three levels suggest that the lower weight gain was not associ-
months. The difference reached statistical significance ated with significant malnutrition.
from the 12th month onward. Proteinuria assessed by The significant cortical atrophy of the kidneys of AA-
SDS-PAGE was characterized in the five tested, AA- treated rabbit was associated with a moderate but diffuse
treated, animals by the presence of low molecular pro- renal interstitial edema, accounting for the fact that their
teins as faint bands (molecular weight of 94 to 14 kD). weight was higher than in control animals. The associa-
No such pattern was observed in control rabbits (N 5 5). tion of interstitial edema with proximal tubule cell dam-
In two of the latter animals, a discrete band at molecular age is reminiscent of the acute tubular necrosis observed
weight of 67 kD was observed together, in one of them, after massive AA dosage [7–10]. A daily, mild, cellular
with another band at 20 kD (data not shown). insult over a period of several weeks might lead to tubular
At the time of sacrifice, hemoglobin levels were lower proteinuria and glucosuria as well as to interstitial fibrosis.
in the treated animals (10.05 6 3.52 vs. 11.54 6 0.45 g/dL A similar sequence of events has been postulated in
in controls; Mann–Whitney test, P 5 0.0125). Serum humans repeatedly given small amounts of mercury [19].
protein levels were slightly but significantly higher in the The three patterns of renal lesions probably correspond
AA-treated group (5.79 6 0.22 vs. 5.50 6 0.27 g/dL in to the increasing sensitivity of individual rabbits to the
controls, Mann–Whitney test, P 5 0.0295). Serum levels toxicity of AA, and they provide some insight into the
of glucose were similar in both control and treated ani- vulnerability of the various nephron segments. The convo-
mals (114.70 6 21.34 and 113.64 6 12.01 mg/dL, respec- luted and straight segments of the superficial and of the
tively). deep nephrons are located, respectively, in the OCL and
Mean systolic/diastolic arterial blood pressures mea- in the MR, and in the ICL and outer stripe of OM in front
sured at 21 months did not differ between treated (N 5 of ICL of the rabbit kidney, as shown schematically in
6) and control (N 5 5) animals: 92.50 6 9.40/73.67 6 Figure 3 [20, 21]. Our data suggest that the first lesions are
observed in the straight part (S3) of the proximal tubule9.87 versus 95.00 6 18.20/74.60 6 18.42 mm Hg.
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Fig. 3. (A) Schematic drawing of the location
in the cortex of the various segments of super-
ficial and deep nephrons in normal rabbits.
(B) The increase of hypocellular interstitial
fibrosis is schematically represented through
three patterns in the kidneys of female New
Zealand White rabbits (N 5 11) injected with
intraperitoneal 0.1 mg AA/kg/day 5/7 days
during 17 (N 5 5) and 21 (N 5 6) months.
Fibrosis is indicated by shades of gray. Abbre-
viations are: OCL, outer cortical labyrinth;
ICL, inner cortical labyrinth; MR, medullary
ray; OS/ICL, outer stripe of outer medulla
(OM) in front of ICL; OS/MR, outer stripe
of outer medulla (OM) in front of MR; IS,
inner stripe of OM; IM, inner medulla. In all
patterns, MRs are extensively involved. In
pattern I, interstitial fibrosis is almost re-
stricted to MR and corresponding OM. This
suggests that the initial insult occurs in the
straight part (S3 segment) of the proximal tu-
bules of the superficial nephrons. In pattern II,
fibrosis has extended to the OCL, suggesting
subsequent involvement of the convoluted
parts (S1 and S2 segments) of the proximal
tubules of the superficial nephrons. In pattern
III, there is additional involvement of ICL and
corresponding OM suggesting extension of in-
jury to the proximal tubules of deep nephrons.
This increase of interstitial fibrosis provides
an explanation for its decreasing intensity
from the OCL to the ICL in these animals.
of superficial nephrons, located in the MR and in the outer kidney, superficial nephrons of the human kidney are
located in the outer cortex and deep nephrons in thestripe of OM adjacent to MR (pattern I; Fig. 3). When
more severe, they extend to the S1 and S2 sections of the inner cortex [20]. Regenerative epithelia mostly found
in the proximal tubules, and hypocellular sclerosis in-proximal convoluted tubule of the same nephrons located
in the OCL (pattern II; Fig. 3). Eventually, they involve volving mainly the outer cortex, have also been reported
in renal biopsies [24] and in end-stage kidneys [23] ofthe proximal part of the deep nephron located in the ICL
and the outer stripe of OM adjacent to ICL (pattern III; patients with CHN.
The similarity between AA renal toxicity and CHNFig. 3). The lack of involvement of the more distal parts
of the nephron accounts for the minimal changes observed is further reinforced by the biologic investigations. Both
conditions are characterized by tubular proteinuria, re-in the inner stripe of the OM and in the IM. These findings
fit with the concept that the proximal segment is the most nal glucosuria, anemia, and a progressive rise in serum
creatinine [1, 25, 26]. Arterial blood pressure remainsvulnerable nephron section to toxic injuries [22].
Several of the morphologic changes observed in our normal in the two models. Furthermore, the kidneys of
both AA-treated rabbits and of CHN patients containedmodel are analogous to those seen in CHN [23, 24].
The corticomedullary gradient of the acellular interstitial the same AA-DNA adducts, whereas those of control
rabbits and control patients were virtually AA-DNAfibrosis is a prominent feature of CHN, illustrated in
Figure 4. It is well matched by the pattern of AA toxicity adducts free (Schmeiser H. and Arlt V., personal com-
munication) [3, 5, 6].illustrated in Figure 2D. Interestingly, just as in the rabbit
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Table 3. Median score of tubular and interstitial lesions (except fibrosis) according to pattern I (N 5 3), II (N 5 2) and III (N 5 6)
AA-treated (N 5 11) and in control (N 5 10) rabbits
Pattern OCL ICL MR Whole OM IM
Proximal tubular cell flattening I 3 (3–4) 2 (2–3) 2 (2–4) 3 (3–4) 0
II 3.5 (3–4) 2.5 (2–3) 4 3.5 (3–4) 0.5 (0–1)
III 4 (3–4) 3 (1–4) 3 (1–4) 4 (3–4) 0
Control 0 0 0 0 0
Tubular atrophy I 2 0 (0–1) 2 (0–3) 1 (0–1) 0
II 2.5 (2–3) 1.5 (1–2) 1.5 (1–2) 1 0
III 3.5 (3–4) 2.5 (1–3) 2 (1–4) 1 (0–2) 0
Control 0 0 0 0 0
Thickened tubular basement membrane I 2 (0–2) 1 (0–1) 1 (0–1) 1 (1–2) 0 (0–1)
II 2 0.5 (0–1) 2 1.5 (1–2) 0
III 3.5 (3–4) 2 (0–3) 2 (0–4) 2 (0–3) 0 (0–3)
Control 0 0 0 0 0
Interstitial edema I 4 (2–4) 4 (1–4) 3 (0–4) 3 (1–4) 0
II 3 (2–4) 2 (1–3) 2.5 (2–3) 3.5 (3–4) 0.5 (0–1)
III 4 (0–4) 3 (0–4) 3 (0–4) 3 (0–4) 0
Control 0 0 0 0 (0–1) 0 (0–2)
Interstitial cellular infiltration I 0 0 0 (0–1) 0 0
II 0.5 (0–1) 0.5 (0–1) 1 1.5 (1–2) 0
III 1 (0–2) 1 (0–2) 1 (0–2) 1 (0–1) 0
Control 0 0 0 0 0
Data are median score with the range in brackets. Scores are: 0 (#0.9% or absent); 1 (1%–9% or minimal); 2 (10%–29% or mild); 3 (30%–59% or moderate);
4 (60%–100% or severe). Abbreviations are: AA, aristolochic acid; OCL, outer cortical labyrinth; ICL, inner cortical labyrinth; MR, medullary ray; OM, outer
medulla; IM, inner medulla.
Table 4. Pooled animal body weight and renal biological data of both groups during the intoxication interval
T area trapezoidal mean through time Slope increase per month
AA-treated Control P value AA-treated Control P value
Body weight kg 4.2060.10 5.4060.20 ,0.001 0.00660.007 0.09760.010 ,0.001
Urine output mL/24 h 276.0635.0 154.0620.0 0.009 8.163.4 25.061.6 0.004
Glucosuria mg/24 h 624.06146.0 0.260.1 0.002 76.00614.00 20.0160.01 ,0.001
Proteinuria mg/24 h 105.0621.0 21.063.0 ,0.001 12.563.1 0.860.3 0.002
Serum creatinine mg/dL 1.4160.05 1.2360.02 0.004 0.03760.006 0.00660.004 ,0.001
Data are mean 6 SEM. P values were calculated by the Mann-Whitney U test.
Finally, AA-treated rabbits as well as CHN patients with advanced disease were never observed in the AA-
treated rabbits [23, 24]. This finding is compatible withdevelop urothelial tumors: Both exhibit atypias of the
collecting duct and the pelvicalyceal urothelium and tu- the hypothesis that vascular lesions of CHN are not in-
duced by AA, but are rather late consequences of ad-mors of the urinary tract [2, 3, 23].
The observation that AA alone (that is, without the vanced kidney destruction.
Finally, the downhill course of renal function wasother components of the slimming pills) can induce le-
sions characteristic of CHN fits well with reports of typi- markedly slower in AA-treated rabbits than in patients
with CHN, although some of the latter occasionally havecal CHN lesions in a few patients who had never attended
the Belgian slimming clinic but who were known to have an almost indolent, slowly progressing nephropathy [25].
The present study highlights species-related differ-utilized drugs containing herbs of the Aristolochia spe-
cies [27–30]. ences in the susceptibility of the kidney to the toxicity
of AA. Acute nephrotoxicity appears similar in humansSeveral differences have to be taken into account when
comparing CHN patients with the experimental AA- and rabbits [7, 8], but is markedly lower in rats and mice
[9, 10], whereas it is virtually absent in dogs, cats, frogs,treated rabbit model. Although rabbits and humans have
a similar sensitivity to the acute toxic effect of AA [7, 8], and porpoises [7]. A similar interspecies difference
emerges for chronic AA nephrotoxicity; in contrast withit is noteworthy that the AA dosage used in this study
to obtain renal lesions is six times higher (on a per weight the rat, which appears immune to chronic AA exposure
[11], rabbits and apparently humans develop severe renalbasis) in the rabbit than that reported in CHN patients
[11]. Furthermore, the 17 to 21 months of exposure to lesions. These interspecies differences might reflect dif-
ferences in the metabolism of AA. AA is a mixture ofAA was comparatively much longer in rabbits than in
humans (,20 months) [2] considering the life expectancy structurally related nitrophenantrene carboxylic acids.
Its major components, AAI and AAII, differ only byof both species.
Renal vascular lesions reported in some CHN patients one methoxy group [31]. All metabolites of AAI, aris-
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Fig. 4. Cortex of patient with end-stage Chi-
nese herbs nephropathy. Hypocellular inter-
stitial fibrosis and tubular atrophy are more
marked in medullary ray (MR) (arrows) and
the outer cortical labyrinth (OCL). Tubules
are still visible in the inner cortical labyrinth
(ICL) (arrowhead). This picture is to be com-
pared with Figure 2D. Periodic acid-Schiff
stain, 330.
tolic acid I, 3,4-methylenedioxy-8-hydroxy-1-phenan- but also in rabbits, as shown for the first time in this
study. It is worth pointing out that whereas AA appearsthrene carboxylic acid, AAIa, aristolactam I and aristo-
lactam Ia, and of AAII, aristolactam II, aristolactam Ia carcinogenic in all tested species (rat, mouse, rabbit,
human), it promotes renal and extrarenal fibrosis in onlyand 3,4-methylenedioxy-1-phenanthrene carboxylic acid
are present in the urine of rats and mice given AA. humans and rabbits. The dissociation of the carcinogenic
and the nephrotoxic effects can be interpreted in twoIn contrast, AAIa and 3,4-methylenedioxy-8-hydroxy-
1-phenanthrene carboxylic acid are missing in the urine ways. AA might operate through two independent mech-
anisms: The first, perhaps through the formation of AA-of rabbits and aristolic acid I, 3,4-methylenedioxy-
8-hydroxy-1-phenanthrene carboxylic acid, AAIa, aris- DNA adducts, would promote the development of tu-
mors, and the second, through direct cytotoxicity, wouldtolactam Ia, and 3,4-methylenedioxy-1-phenanthrene
carboxylic acid in the urine of humans [32]. induce renal tubular lesions and acellular interstitial fi-
brosis. Alternatively, it might be speculated that AAAs initially pointed out by Mengs, AA is a potent
carcinogenic compound not only in rats and mice [33, 34], toxicity results from alterations of cellular DNA but that
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phropathy-associated slimming regimen induces tumours in theregulation. A further comparison of the AA rabbit and
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